A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
NCT00002270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To study the effectiveness of alpha interferon (IFN-A2b) and zidovudine (AZT) in treating progressive multifocal leukoencephalopathy (PML) as a complication of HIV-1 infection.
Conditions
- HIV Infections
- Leukoencephalopathy, Progressive Multifocal
Interventions
- DRUG
-
Interferon alfa-2b
- DRUG
-
Zidovudine
Sponsors & Collaborators
-
University of Miami
lead OTHER
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)
NCT01939002 ·Status: COMPLETED ·Phase: PHASE3
-
REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients
NCT01171209 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
NCT00344253 ·Status: COMPLETED ·Phase: PHASE3
-
Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
NCT00493116 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
NCT00037102 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis
NCT00906399 ·Status: COMPLETED ·Phase: PHASE3
-
Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis
NCT02364986 ·Status: UNKNOWN ·Phase: PHASE1
-
NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy
NCT04781309 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison Study of PF530 and Betaferon in Healthy Subjects
NCT02474134 ·Status: COMPLETED ·Phase: PHASE1
-
Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis
NCT01395316 ·Status: COMPLETED ·Phase: PHASE4
-
Zenapax to Treat Multiple Sclerosis
NCT00001934 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Memory in Patients With Multiple Sclerosis
NCT00062972 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
NCT00242268 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
NCT00050778 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis
NCT05078177 ·Status: UNKNOWN ·Phase: PHASE1
-
Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses
NCT02087813 ·Status: WITHDRAWN ·Phase: PHASE1
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
NCT00004744 ·Status: COMPLETED ·Phase: PHASE3
-
The Regulatory Role of miRNA 27 Follistatin Like Protein-1 Gene in Multiple Scelerosis
NCT06290453 ·Status: NOT_YET_RECRUITING
-
Long-Term Safety and Efficacy Study of Peginterferon Beta-1a
NCT01332019 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
NCT01252355 ·Status: TERMINATED ·Phase: PHASE3
-
Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis?
NCT02236624 ·Status: COMPLETED ·Phase: NA
-
Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis
NCT01337427 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis
NCT00004816 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
NCT00883337 ·Status: COMPLETED ·Phase: PHASE3
-
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
NCT06592703 ·Status: RECRUITING ·Phase: PHASE1